The purpose of this clinical trial is to learn about how the safety, how well the study medicine works, extent to which side affects can be tolerated, and how the study medicine is changed and eliminated from your body after you apply it on your skin. The study medicine is in ointment form.
2 Primary · 19 Secondary · Reporting Duration: Week 1, 2, 4, 6, 8, 10, 12, and Follow-up
240 Total Participants · 7 Treatment Groups
Primary Treatment: Plaque Psoriasis PF-07038124 0.06% ointment · Has Placebo Group · Phase 2
Age Any Age · All Participants · 8 Total Inclusion CriteriaMark “Yes” if the following statements are true for you: